Fairvalue-Calculator Fairvalue-Calculator

PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO) Fair Value & Analysis

Consumer Defensive · ID · Market cap 11.0T IDR

Price374.00 IDR
Fair Value742.91 IDR
Upside+98.6%
Quality95/100
Evidence: High Range 493.31 IDR – 986.35 IDR

Analysis

PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO) currently trades at 374.00 IDR, while our model-based Fair Value estimate is 742.91 IDR — implying the stock looks roughly 98.6% undervalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

PT Industri Jamu dan Farmasi Sido Muncul Tbk provides herbal medicines, cosmetics, and foods and beverage products in Indonesia. The company operates through three segments: Herbal Medicine and Supplements; Food and Beverage; and Pharmacy. It also offers medicine products comprising ethical/prescriptions and OTCs; herbal products, such as traditional herbals, food and beverages, herbal medicines, supplements, vitamins, and mom, kids, and baby products; and powder and liquid herbal ingredients for ache and pain relief, antibiotics, anemia, anti-allergy, antioxidants, blood pressure, brain function, bone health, children's health, cold, flu, and cough, diabetes, digestion, energy and vitality, heart and cholesterol, immune system, joints and mobility, liver and detox, men's and skin health, sleep aids, tumor and cancer, weight management, women's health, and others. In addition, it is involved in commerce, land transportation, wastewater treatment, and plantation and printing activiti…

Open the full interactive analysis →

Similar stocks

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.